Literature DB >> 12393946

The ORL1 receptor: molecular pharmacology and signalling mechanisms.

David C New1, Yung H Wong.   

Abstract

The cloning of the opioid-receptor-like 1 (ORL(1)) receptor and the identification of nociceptin as its endogenous agonist have revealed a new G-protein-coupled receptor signalling system. The structural and functional homology of ORL(1) to the opioid receptor systems has posed a number of challenges in understanding the often competing physiological responses elicited by these G-protein-coupled receptors. Thus, this review will attempt to summarize recent research by many groups that has revealed numerous subtleties of the ORL(1) receptor and its signalling pathways, as well as document the efforts to produce high-affinity selective ligands for the ORL(1) receptor that may be of value as research and therapeutic tools. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393946     DOI: 10.1159/000065432

Source DB:  PubMed          Journal:  Neurosignals        ISSN: 1424-862X


  25 in total

1.  Early role of the κ opioid receptor in ethanol-induced reinforcement.

Authors:  Ricardo Marcos Pautassi; Michael E Nizhnikov; Ma Belén Acevedo; Norman E Spear
Journal:  Physiol Behav       Date:  2012-01-11

2.  Study on the activation of the opioid receptors by a set of morphine derivatives in a well-defined assay system.

Authors:  Yan Zhang; Zhiwei Wang; D Phillip Cox; Olivier Civelli
Journal:  Neurochem Res       Date:  2011-10-16       Impact factor: 3.996

Review 3.  Nociceptin and the nociceptin receptor in learning and memory.

Authors:  Raül Andero
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-02-24       Impact factor: 5.067

4.  Nociceptin/Orphanin FQ Inhibits the Survival and Axon Growth of Midbrain Dopaminergic Neurons Through a p38-MAPK Dependent Mechanism.

Authors:  Louise M Collins; Giorgia Dal Bo; Mariangela Calcagno; Jimena Monzón-Sandoval; Aideen M Sullivan; Humberto Gutierrez; Michele Morari; Gerard W O'Keeffe
Journal:  Mol Neurobiol       Date:  2015-12-21       Impact factor: 5.590

5.  In silico study of the structurally similar ORL1 receptor agonist and antagonist pairs reveal possible mechanism of receptor activation.

Authors:  Milan Senćanski; Ljiljana Dosen-Mićović
Journal:  Protein J       Date:  2014-06       Impact factor: 2.371

6.  Phosphoproteomic and Functional Analyses Reveal Sperm-specific Protein Changes Downstream of Kappa Opioid Receptor in Human Spermatozoa.

Authors:  Itziar Urizar-Arenaza; Nerea Osinalde; Vyacheslav Akimov; Michele Puglia; Luz Candenas; Francisco Maria Pinto; Iraia Muñoa-Hoyos; Marta Gianzo; Roberto Matorras; Jon Irazusta; Blagoy Blagoev; Nerea Subiran; Irina Kratchmarova
Journal:  Mol Cell Proteomics       Date:  2019-01-08       Impact factor: 5.911

7.  Binding of the novel radioligand [(3)H]UFP-101 to recombinant human and native rat nociceptin/orphanin FQ receptors.

Authors:  Massimo Ibba; Masato Kitayama; John McDonald; Girolamo Calo; Remo Guerrini; Judit Farkas; Geza Toth; David G Lambert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-09-21       Impact factor: 3.000

8.  Participation of the nociceptin/orphanin FQ receptor in ethanol-mediated locomotor activation and ethanol intake in preweanling rats.

Authors:  Roberto Sebastián Miranda-Morales; Michael E Nizhnikov; Dustin H Waters; Norman E Spear
Journal:  Behav Brain Res       Date:  2013-02-21       Impact factor: 3.332

Review 9.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

10.  Coupling specificity of NOP opioid receptors to pertussis-toxin-sensitive Galpha proteins in adult rat stellate ganglion neurons using small interference RNA.

Authors:  Wojciech Margas; Khaled Sedeek; Victor Ruiz-Velasco
Journal:  J Neurophysiol       Date:  2008-06-18       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.